This page includes the latest FDA filings for Acerus Pharmaceuticals Corp. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
CANADA | TORONTO STOCK EXCHANGE | ASP | DUNS 243912362 |
Device Company | Device | Date |
---|---|---|
Acerus Pharmaceuticals Corporation | Prescription Medication | 2022-12-20 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2021-12-23 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-11-14 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-21 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-19 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-16 |
Acerus Pharmaceuticals Corporation | Prescription Medication | 2020-05-15 |
Acerus Pharmaceuticals Corporation | Natesto | 2020-05-08 |
NCAGE Code | L0MW0 | ACERUS PHARMACEUTICALS CORPORATION |
SEC | 0001527246 | Acerus Pharmaceuticals Corp of ONTARIO, CANADA |